Department of Psychiatry and Biobehavioral Sciences, Stefan Hatos Center for Neuropharmacology, Semel Institute, University of California, Los Angeles, Los Angeles, CA 90095, USA.
Cell Rep. 2013 Nov 27;5(4):1010-21. doi: 10.1016/j.celrep.2013.10.015. Epub 2013 Nov 14.
G-protein-coupled receptors (GPCRs) are typically present in a basal, inactive state but, when bound to an agonist, activate downstream signaling cascades. In studying arrestin regulation of opioid receptors in dorsal root ganglia (DRG) neurons, we find that agonists of delta opioid receptors (δORs) activate cofilin through Rho-associated coiled-coil-containing protein kinase (ROCK), LIM domain kinase (LIMK), and β-arrestin 1 (β-arr1) to regulate actin polymerization. This controls receptor function, as assessed by agonist-induced inhibition of voltage-dependent Ca(2+) channels in DRGs. Agonists of opioid-receptor-like receptors (ORL1) similarly influence the function of this receptor through ROCK, LIMK, and β-arr1. Functional evidence of this cascade was demonstrated in vivo, where the behavioral effects of δOR or ORL1 agonists were enhanced in the absence of β-arr1 or prevented by inhibiting ROCK. This pathway allows δOR and ORL1 agonists to rapidly regulate receptor function.
G 蛋白偶联受体(GPCRs)通常处于基础的、非活跃状态,但与激动剂结合后,会激活下游信号级联反应。在研究背根神经节(DRG)神经元中阿片受体的抑制素调节时,我们发现 δ 阿片受体(δOR)的激动剂通过 Rho 相关卷曲螺旋蛋白激酶(ROCK)、LIM 结构域激酶(LIMK)和β-抑制素 1(β-arr1)激活丝切蛋白,从而调节肌动蛋白聚合。这可以控制受体功能,如通过在 DRG 中激动剂诱导的电压依赖性 Ca(2+)通道抑制来评估。阿片受体样受体(ORL1)的激动剂也通过 ROCK、LIMK 和 β-arr1 类似地影响该受体的功能。在体内证明了该级联的功能证据,其中 δOR 或 ORL1 激动剂的行为效应在缺乏 β-arr1 时增强,或通过抑制 ROCK 来预防。该途径允许 δOR 和 ORL1 激动剂快速调节受体功能。